Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$34.5 - $42.19 $20,182 - $24,681
-585 Reduced 25.31%
1,726 $72,000
Q1 2023

May 11, 2023

SELL
$33.32 - $40.98 $5,464 - $6,720
-164 Reduced 6.63%
2,311 $82,000
Q4 2022

Feb 10, 2023

BUY
$25.32 - $51.45 $48,766 - $99,092
1,926 Added 350.82%
2,475 $90,000
Q3 2022

Nov 10, 2022

BUY
$46.5 - $79.14 $13,485 - $22,950
290 Added 111.97%
549 $26,000
Q2 2022

Aug 09, 2022

BUY
$63.06 - $84.75 $10,152 - $13,644
161 Added 164.29%
259 $19,000
Q1 2022

May 06, 2022

SELL
$74.15 - $99.36 $3,188 - $4,272
-43 Reduced 30.5%
98 $8,000
Q4 2021

Feb 01, 2022

BUY
$86.01 - $102.89 $344 - $411
4 Added 2.92%
141 $14,000
Q3 2021

Nov 12, 2021

BUY
$84.7 - $96.31 $10,841 - $12,327
128 Added 1422.22%
137 $12,000
Q2 2021

Aug 09, 2021

BUY
$76.44 - $89.57 $76 - $89
1 Added 12.5%
9 $1,000
Q2 2020

Aug 13, 2020

SELL
$34.32 - $62.43 $28,348 - $51,567
-826 Reduced 99.04%
8 $0
Q1 2020

May 15, 2020

BUY
$32.64 - $73.63 $1,338 - $3,018
41 Added 5.17%
834 $32,000
Q4 2019

Feb 03, 2020

BUY
$48.0 - $59.55 $1,536 - $1,905
32 Added 4.2%
793 $46,000
Q2 2019

Jul 24, 2019

BUY
$40.81 - $52.42 $29,668 - $38,109
727 Added 2138.24%
761 $38,000
Q4 2018

Jan 17, 2019

BUY
$36.49 - $51.72 $1,240 - $1,758
34 New
34 $1,000
Q2 2018

Aug 09, 2018

SELL
$35.0 - $48.9 $3,465 - $4,841
-99 Closed
0 $0
Q1 2018

May 10, 2018

SELL
$31.7 - $44.1 $126 - $176
-4 Reduced 3.88%
99 $3,000
Q4 2017

Jan 31, 2018

BUY
$34.35 - $59.0 $3,538 - $6,077
103
103 $3,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.